Femtech Market by Type (Software, Services, Devices, Others); by Applications (Pregnancy & Nursing Care, Reproductive Health, General Healthcare & Wellness, Pelvic & Uterine Healthcare, Others); by End User (Hospitals, Direct-to-Customer, Diagnostic Centers, Fertility Clinics, Others); by Region (North America, Europe, Asia-pacific, Latin America, Middle East Africa): Global Forecasts 2021 To 2027

The Global Femtech Market size was valued at USD 22.6 Bn in 2020 and is expected to reach USD 63.4 Bn by 2027, with a growing CAGR of 16% during the forecast period.

Femtech (Female technology) refers to the software, services, products, and devices that requires use of technology to focus on women’s health. This includes period trackers, fertility solutions, women’s sexual wellness, pregnancy and nursing care, and reproductive health management products or services. For instance, digital platform for endometriosis helps to keep the track on regular check-in and painful disorder management.  

Femtech Market Dynamics

The driving factors for the global femtech market include growing fertility solution, rising concern regarding women’s health & wellness, and increasing reproductive infectious diseases. Moreover, growing awareness regarding female health apps & products and penetration of technology in the healthcare management such as involvement of technology in apps, healthcare software & devices are expected to leverage the growth of the global femtech demand. Besides, growing prevalence of the menstrual cycle problems, PCOD, and knowledge regarding personal hygiene management is expected to fuel the growth of femtech demand across the globe.

For instance, femtech startup named Lady Technologies (US) launched dual-purpose device called Kegg that is designed to measure the hormonal changes in cervical fluid that would help to analyze and determine women’s chances of conception on a given day. Such innovative technologies are expected to uplift the demand of the industry across the world. In addition, increasing presence of female workforce in the technological healthcare and female hygiene solutions give rise to the femtech start-ups that are rule by women. This helps to empower women as well as contribute to the increase in number of female health management companies across the world.

Such upcoming companies in female technology is expected to increase the overall revenue of the femtech demand across the globe during forecast period. On the contrary, lack of knowledge regarding available women's health products and interference of stringent regulatory policies for product launch is expected to hinder the growth of femtech market demand.

 Global Femtech Market Segmentation:

By Type

• Software
• Services
•  Devices
• Others

By Applications

• Pregnancy & Nursing Care
•  Reproductive Health
• General Healthcare & Wellness
•  Pelvic & Uterine Healthcare
•  Others

By End Users

• Hospitals, Direct-to-Customer
• Diagnostic Centers
• Fertility Clinics
• Others

By Region

• North America
• Europe
• Asia-Pacific
• Latin America
• Middle East & Africa

Based on applications, pregnancy & nursing care segment is expected to hold the largest market share during forecast period owing to rising pregnancy complications

Based on applications, femtech market is broadly segmented into pregnancy & nursing care, reproductive health, general healthcare & wellness, and pelvic & uterine healthcare. Pregnancy & nursing care segment held the largest market share in 2020 and is expected to increase more during the forecast period owing to increase in the number of pregnancy cases.

For instance, Amma pregnancy tracker, an international smartphone app that serve world largest communities for families and pregnant women. Amma pregnancy tracker provides evidence-based pregnancy information & provide recommendations from doctors to the patients, and this would help to keep track on their health.

Based on end users, hospital segment is expected to contribute the highest to the market during forecast period due to availability of end-to-end facilities in the hospitals

Based on end users, femtech market is broadly segmented into hospitals, direct-to-customer, diagnostic centers, and fertility clinics. Hospital segment is expected to dominate the market during forecast period due to presence of skilled professionals and high through patient care service. Moreover, availability of reimbursement policies and accessibility of diagnostic equipment's in the hospital is expected to boost the growth of the femtech demand.

Based on geographical region, North America is expected to dominate the market during forecast period due to large volume of population are vulnerable to the chronic infectious diseases

Based on region, North America held the largest market share in 2020 and is expected to increase more during forecast period due to presence of strong government support in terms of spreading awareness regarding reproductive health management. Moreover, availability of healthcare infrastructure and increase in spending of women’s healthcare is expected to boost the growth of segment in ecosystem. Growing penetration of artificial intelligence in the healthcare and rising awareness regarding personal hygiene care is expected to uplift the growth of femtech demand in this region.

Company Profiles and Competitive Intelligence

The key players operating in the femtech market are:

• HeraMED
• Progyny
•  Totohealth
•  Sustain Natural
•  Nuvo
•  Athena Feminine Technologies
• Minerva
• iSono Health
• Sera Prognostics
•  BioWink
• Elvie
• Clue
• Aparito Limited
• Bloomlife
• Bonzun Health Information AB
• Ava Science Inc.
• Grace Health
• iBreve
• LactApp
• Natural Cycles Nordic AB
• Hera Med Ltd.
• Niramai Health
• NURX Inc.
• SteadySense GmbH
• Pregnolia AG
• Willow
• WOOM
• B-wom

The report also provides an in-depth analysis of femtech market dynamics such as drivers, restraints, opportunities, and challenges

Drivers

• Penetration of technology in healthcare
• Growing need for regular reproductive health tracking
• Rising concern regarding reproductive infectious diseases
• Emergence of innovative products and services related to women hygienic health

Restraints

• Pace of education
• Availability of alternative feminine products and services

Opportunity

• Growing awareness regarding female health services and products
• Increase in funding for consumer health technology
• Emergence of new start-ups in femtech industry

Challenges

• Lack of awareness regarding femtech products and apps
• Growing economic burden hinder penetration of female products, smart phones, and devices in rural and other regions of the world

COVID-19 Impact on the Femtech Market Analysis

Covid-19 has positively impacted the growth of femtech market due to rise in use of software, devices, and apps for reproductive health management. During lockdown, unavailability of doctors and skilled staffs diverted the attention of female population towards software and devices to manage reproductive health. Moreover, according to the surveys, women’s health suffered from mental illness and elevation in pregnancy rates during covid outbreak. To manage such situations, many pharma-tech companies designed and developed female health management and consulting software which boosted the growth of the femtech demand across the globe.

Besides, growing need for femtech services in spreading awareness and diagnostics regarding neonatal and maternal care during pandemic facilitated the use of female health technology and uplifted the femtech demand of the ecosystem. On the other hand, pandemic strengthen the gap for healthcare service providers which in turn increase the adaption of digital solution for health management. According to the surveys, adoption rate of digital services during pandemic showed increased by ~10% across the globe.

The report also provides an in-depth analysis of key trends in femtech market

• Growing tractions towards femtech devices such as period tracking, fertility tracking devices
• Rise in holistic health approaches and preventative medicine

The report also provides an in-depth analysis of recent news developments and investments

• In March 2021, DotLab announced the beginning of EMPOWER, a cohort study for endometriosis. Endometriosis is the disorder of uterus in which tissue grow outside the uterus and prove to be painful. This study is expected to support the future research and development activities of the company that aid non-invasive diagnosis test for endometriosis. This proposal is expected to leverage the services of the company.
• In September 2020, HeraMed joined hands with eCare21 a virtual platform to combine heartCARE & heartBEAT products with eCare21. This partnership is expected to offer evaluation for efficacy and utility of the HeraCARE platform which prove to be the key progress for the company’s marketing strategy in the U.S. This partnership is expected to enhance product development and portfolio capabilities of the company.

The unique insights provided by this report also includes the following:

• In-depth Value Chain Analysis
• Opportunity Mapping
• Sector Snapshot
• Key Players Positioning Matrix
• Regulatory Scenario
• Strategies Adopted-Benchmarking Heat Map
• Market Trends
• Covid-19 Impact Analysis
• Product Comparison
• Pre & Post COVID 19 Impacts on Femtech Market
• Competitive Landscape

Frequently Asked Questions (FAQs)

Related Reports